ARUP Newsroom

This issue highlights milestones in ARUP’s history, gives a glimpse into the company’s future, and includes a special feature: a video of ARUP founders and current leaders reminiscing and celebrating.

ARUP maintains that the FDA’s rule will limit access to testing, stifle innovation, and increase healthcare costs.

Nicola Longo, who with his wife, Marzia Pasquali, is credited with expanding screening for a treatable metabolic disorder, is leaving for UCLA while Pasquali stays at ARUP to continue key projects.

A new partnership between ARUP and connectivity provider ELLKAY aims to give health systems the testing support, guidance, and technology needed to establish or expand lab outreach operations.

Jan Wintch, CQA(ASQ), senior quality specialist, has worked at ARUP since the company’s inception. She enjoys her current role in Quality and remembers ARUP’s early years fondly.

The ARUP Consult Laboratory Testing for Developmental Delay, Intellectual Disability, and Autism Spectrum Disorder topic now includes exome and genome sequencing as a first- or second-tier test.

Join ARUP in kickstarting Lab Week with a curated selection of podcasts, articles, and lectures that emphasize the important role medical lab professionals play in improving and saving patient lives.

ARUP medical directors and experts will be present to discuss the latest developments in neurology laboratory testing at the upcoming American Academy of Neurology (AAN) Annual Meeting.